Motilal Oswal expects the Symbiotec Pharmalabs' revenue to grow at a 33% CAGR to ₹2,030 crore, EBITDA to also grow at a 33% ...

The planned resumption of commercial semaglutide supplies in November 2026 remains on track, HSBC said, while citing that execution will be crucial for the company to gain market share. It also ...

Indian investment platforms like Groww, Zerodha, Angel One, and Upstox are expanding US stock and ETF access through GIFT ...

JSW Steel expects sequential improvement in EBITDA margins during the October-December quarter as higher steel prices offset ...

Smoke was seen rising from behind North Block in New Delhi on Monday, raising concerns of a fire near Parliament. Fire ...

Infosys is going to be the result reaction of the day to watch along with a slew of banking and financial names like Kotak ...

US President Donald Trump says the US-Canada trade dispute will be settled soon, as tariffs on Canadian goods face scrutiny ...

Cyclone Arnab intensifies over the Bay of Bengal, threatening the Andhra Pradesh and Odisha coasts with heavy rainfall and ...

Explore the latest updates including IndiGo and Air India Express shifting flights to Navi Mumbai airport and financial news ...

Management identified El Niño, deficient rainfall and elevated oil prices as key risks to monitor. The third quarter will be ...

The Star MF and co-location businesses broader BSE's earnings drivers beyond just trading activity, the Motilal Oswal note ...

BofA Global Research has turned positive on the Nifty after more than two years of caution but continues to expect a deeper ...